SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) was down 1.2% during trading on Thursday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Price Performance
The stock has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81. The firm has a 50 day simple moving average of $24.38 and a two-hundred day simple moving average of $24.38.
SWEDISH ORPHAN/S Company Profile
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
Recommended Stories
- Five stocks we like better than SWEDISH ORPHAN/S
- Stock Average Calculator
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Consumer Discretionary Stocks Explained
- Breakout Alert: Qualcomm Just Hit The Rally Button
- What is a buyback in stocks? A comprehensive guide for investors
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
